MaxCyte, Inc.
MXCT
$1.39
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.77M | -41.79M | -41.06M | -35.74M | -35.43M |
| Total Depreciation and Amortization | 5.17M | 5.07M | 5.02M | 4.99M | 5.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.13M | 10.27M | 9.17M | 8.20M | 7.51M |
| Change in Net Operating Assets | -8.01M | -5.01M | -751.00K | 3.74M | 259.00K |
| Cash from Operations | -36.48M | -31.46M | -27.61M | -18.81M | -22.66M |
| Capital Expenditure | -1.79M | -1.50M | -1.65M | -2.42M | -2.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -1.77M | -1.77M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.57M | 34.13M | 8.58M | 6.88M | 6.40M |
| Cash from Investing | 13.01M | 30.86M | 6.93M | 4.46M | 3.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.18M | 1.74M | 2.06M | 2.14M | 1.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.18M | 1.74M | 2.06M | 2.14M | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.29M | 1.14M | -18.62M | -12.21M | -17.05M |